Results 301 to 310 of about 674,005 (346)
Some of the next articles are maybe not open access.
Trypsinogen, Trypsin, Trypsin-Substrate and Trypsin-Inhibitor Complexes in Urea Solutions
European Journal of Biochemistry, 1968The denaturation in urea of trypsinogen, trypsin and trypsin derivatives is first-order with respect to protein. 1 Structural modifications affecting the trypsinogen molecule were detected by studying the influence of pH on the rate of denaturation. The acidification of trypsinogen leads to the appearance of 2 reversible equilibria I′⇌ II′⇌ III′
M, Delaage, M, Lazdunski
openaire +2 more sources
Journal of Allergy, 1964
T rypsin (Parenzyme) is used extensively in the treatment of a variety of disorders.1-26 These conditions include thrombophlebitis, peripheral vascular disease, venous thrombosis, postoperative edema, traumatic swelling, hematomas, ulcerative lesions, postphlebitic syndrome, etc.
L H, CRIEP, L R, BEAM
openaire +2 more sources
T rypsin (Parenzyme) is used extensively in the treatment of a variety of disorders.1-26 These conditions include thrombophlebitis, peripheral vascular disease, venous thrombosis, postoperative edema, traumatic swelling, hematomas, ulcerative lesions, postphlebitic syndrome, etc.
L H, CRIEP, L R, BEAM
openaire +2 more sources
The Journal of Biochemistry, 1982
We devised a new separation technique for the protein, "affinophoresis," which is based on its specific affinity and utilizes electrophoresis. This technique requires a carrier macromolecule, "affinophore," which contains both an affinity ligand for a certain protein and many charges, either positive or negative, in order to migrate rapidly in an ...
K, Shimura, K, Kasai
openaire +2 more sources
We devised a new separation technique for the protein, "affinophoresis," which is based on its specific affinity and utilizes electrophoresis. This technique requires a carrier macromolecule, "affinophore," which contains both an affinity ligand for a certain protein and many charges, either positive or negative, in order to migrate rapidly in an ...
K, Shimura, K, Kasai
openaire +2 more sources
Chitosan nanoparticles conjugate with trypsin and trypsin inhibitor
Carbohydrate Polymers, 2016Chitosan-protein conjugates are widely used in therapeutic drug delivery. We report the bindings of chitosan nanoparticles with trypsin (try) and trypsin inhibitor (tryi), using thermodynamic analysis and multiple spectroscopic methods. Thermodynamic parameters ΔS, ΔH and ΔG showed chitosan-protein bindings occur mainly via H-bonding and van der Waals ...
P, Chanphai, H A, Tajmir-Riahi
openaire +2 more sources
Trypsin Uptake and Trypsin-Inhibitor Complexes
Neonatology, 1989Previous studies have suggested that both newborn animals and humans absorb intact proteases from the intestine in greater amounts than do adults. Absorbed proteases are rapidly complexed in plasma by several inhibitors which inactivate free proteases. In order to confirm increased intestinal uptake in newborns, we evaluated the plasma trypsin activity
Jeremiah J. Levine +3 more
openaire +1 more source
CELLS ISOLATED FROM TRYPSIN‐TREATED BRAIN CONTAIN TRYPSIN
Journal of Neurochemistry, 1976Abstract—Neuronal and oligodendroglial cell fractions isolated from trypsinized brain contain trypsin. Neuronal cell bodies contained approximately 5 μg of trypsin/mg of cell protein; oligodendroglial cells had approx 1 μg of enzyme activity. Studies with fluorescein‐conjugated trypsin suggested that least a portion of the fluorescent enzyme was ...
M, Guarnieri, S R, Cohen, E, Ginns
openaire +2 more sources